Does Mad Honey Get You High? What the Science Says

Straightforward answer: no, not in the way the question usually implies. Mad honey contains grayanotoxin, a compound that disrupts voltage-gated sodium channels in nerves and the heart. The effects it produces, dizziness, tingling, slowed heart rate, blood pressure drop, and altered sensation, are physiological, not psychedelic. There is no euphoria, no serotonin receptor activation, no altered perception of reality in the classical sense of those terms.

What people experience and describe as a ‘high’ from mad honey is the result of cardiovascular disruption and peripheral nervous system interference, a different mechanism entirely from any substance that pharmacologists would classify as psychoactive.

What Actually Happens in the Body

Understanding the real effect requires separating what GTX does from the vocabulary typically used to describe it.

Below the intoxication threshold

At small amounts, well below what the clinical literature associates with poisoning, most people report little to no noticeable effect. Some describe mild tingling, a slight warmth, or very faint light-headedness. Whether this represents a genuine physiological response or expectation effect is not established in the literature, because sub-threshold consumption has not been studied in controlled conditions.

At intoxicating amounts

Documented poisoning cases in the clinical literature involve consumption of roughly 15–30 grams, though this figure is imprecise because GTX concentration varies enormously between batches, and the same gram weight of honey from different jars can contain radically different amounts of active compound. At amounts associated with clinical intoxication, the documented effects are:

• Dizziness and difficulty standing: caused by blood pressure dropping as GTX promotes vasodilation and simultaneously slows the heart. Less blood is reaching the brain. The sensation is similar to standing up too quickly from a seated position, but sustained and progressive rather than transient.
• Tingling and paraesthesia spreading through the body: caused by GTX disrupting sodium channel function in peripheral sensory neurons, producing abnormal firing patterns. This is one of the most commonly reported early signs in clinical case series.
• Slowed heart rate (bradycardia): GTX stimulates the vagal nervous system, which applies braking pressure to the heart. In documented cases, heart rates drop to 40–50 beats per minute and below. This is not a subtle effect.
• Nausea and gastrointestinal discomfort: consistent with the cholinergic pattern GTX produces.
• Visual disturbances: blurred vision and diplopia (double vision) are documented in case literature. These are caused by the effect of sodium channel disruption on the nerves controlling eye muscle coordination, compounded by reduced cerebral blood flow. They are not hallucinations.
• In severe cases: inability to walk, pronounced hypotension, and, in the most serious presentations, cardiac conduction abnormalities, including atrioventricular block, requiring emergency treatment.

Duration

GTX is metabolised and cleared from the body within approximately 24 hours. Effects typically peak within 1–3 hours of consumption and resolve within 24 hours in most documented cases, assuming no further consumption and absent pre-existing cardiac conditions that complicate the picture.

Is It Like Being Drunk or High on Cannabis?

These are the comparisons most first-time searchers are implicitly making, and they deserve a direct answer rather than deflection.

Compared to alcohol

The closest everyday parallel is alcohol intoxication at the level of significant impairment, difficulty standing, dizziness, impaired coordination, and nausea. But the mechanism is different. Alcohol produces CNS depression through GABA receptor enhancement and glutamate inhibition, among other effects. GTX produces cardiovascular disruption through sodium channel toxicity. 

The surface-level experience of physical impairment overlaps; the underlying pharmacology does not. Critically, alcohol’s physiological risk at moderate doses is lower than GTX’s, and the dose-response relationship is better characterised. People can calibrate alcohol consumption based on experience in a way they cannot reliably calibrate GTX consumption.

Compared to cannabis

Cannabis acts on CB1 endocannabinoid receptors in the brain, producing euphoria, altered time perception, appetite stimulation, and, in some cases, anxiety or mild perceptual changes. GTX does none of this. There is no CB1 involvement, no limbic system action, no mood elevation. The physiological effect profile is entirely different.

Compared to psychedelics

LSD, psilocybin, and DMT act on 5-HT2A serotonin receptors in the cortex, producing genuine alteration of perception , visual pattern enhancement, ego disruption, and altered sensory integration. GTX has no documented action on serotonin receptors. The visual disturbances from mad honey are symptoms of hypoperfusion and peripheral nerve disruption, not cortical serotonergic effects. The experience may feel unusual; it does not constitute a psychedelic state.

For the full pharmacological comparison, including a mechanism comparison table, see the CMHI article: “Hallucinogenic Honey” Explained.

Why Does Everyone Say It Gets You High?

The framing has three primary sources, none of which required deliberate misinformation.

Documentaries and media coverage: multiple major broadcasters have filmed the Gurung honey hunters of Nepal and described the honey’s effects using psychedelic vocabulary. The visuals are compelling, the vocabulary is familiar, and the pharmacological distinction between sodium channel toxicity and serotonin receptor agonism was not part of the editorial brief.

Commercial framing: ‘get you high’ drives search traffic and sales in ways that accurate clinical vocabulary does not. The language is repeated across product descriptions and review sites until it has the appearance of an established fact.

The experience itself: at intoxicating doses, mad honey produces a genuinely disorienting physical state. Significant dizziness, tingling throughout the body, visual disturbances, and an inability to stand are collectively unusual enough that people reach for the closest available vocabulary. Psychedelic and high are the words most readily available for unusual experiences that alter the way you feel and function. The category error follows from applying them to a state that belongs in a different classification.

What Determines How Strong the Effect Is

The most important variable is not how much honey you consume in grams; it is the grayanotoxin concentration of the specific batch you are consuming from.

A 2022 LC-MS/MS study of 60 Nepalese mad honey samples found GTX I concentrations ranging from 0.75 to 64.86 µg/g, an 86-fold difference between the lowest and highest measurements. GTX III showed a 255-fold range. Two jars, both labelled ‘mad honey from Nepal’ and purchased from the same seller, can contain concentrations that are orders of magnitude apart. The same spoonful from each jar represents a fundamentally different physiological exposure.

This is why gram-weight dosing guidance, ’15–30g produces intoxication’, should be treated with significant caution. That figure comes from clinical case reports where honey concentration was not measured. It describes what happened in specific documented cases, not a reliable threshold that applies uniformly across all batches.

Other variables that affect how strong the effect is: individual sensitivity to GTX (influenced by age, body weight, baseline heart rate, and medication use), speed of consumption, and whether food was eaten beforehand. People with lower baseline blood pressure or slower baseline heart rates are more sensitive to GTX’s cardiovascular effects at any given dose.

Who Should Not Consume Mad Honey

Several populations face a significantly elevated risk from any exposure to GTX, regardless of batch concentration or consumption amount.

• People with pre-existing cardiac conditions: anyone with a history of bradycardia, heart block, sick sinus syndrome, or other arrhythmias. GTX slows the heart and disrupts conduction; these effects are additive to existing cardiac dysfunction.
• People on beta-blockers, calcium channel blockers, antihypertensive medications, or cardiac glycosides: all of these drug classes have documented interaction potential with GTX’s cardiovascular effects. Bradycardia from GTX combined with beta-blockade can be severe.
• Elderly people and those with baseline low blood pressure: greater sensitivity to hypotensive effects at any given GTX exposure level.
• Pregnant individuals: no safety data exists; consumption is not recommended.

Anyone without a confirmed COA showing the GTX concentration of their specific batch.

For the complete contraindications list, see the CMHI Safety Standard article: Who Should Not Take Mad Honey. For specific drug interactions, see: Mad Honey Medication Interactions.

What to Do If You Have Had Too Much

The following symptoms indicate that GTX exposure has reached a level requiring medical attention:

Heart rate has slowed noticeably and stays slow. A resting heart rate below 50 beats per minute is documented as a threshold for clinical concern in the case literature.

• Significant difficulty standing or maintaining orientation, beyond mild dizziness.
• Pronounced nausea or vomiting that you cannot manage.
• Visual disturbances that persist or worsen.
• Loss of consciousness or near-syncope.

If any of these are present, stop consuming. Lie down to reduce the hemodynamic stress of upright posture. Do not consume more honey in the hope of evening out the effect. If bradycardia is severe or you cannot maintain consciousness, call emergency services.

The clinical treatment is effective: atropine sulphate reverses the vagal effects of GTX in most cases. IV saline addresses hypotension. Most documented patients recover within 24 hours with appropriate treatment. The keyword is appropriate, which requires reaching a medical facility.

For a detailed emergency reference, see the CMHI Safety Standard article: Emergency Response, Recognising and Responding to Mad Honey Adverse Effects.

What We Don’t Know Yet

No controlled human study on the neurological effects of GTX exists. Every symptom in this article comes from emergency case reports , patients who consumed enough to require medical attention , and from animal research. What GTX does to human neurological function at amounts that do not require emergency treatment has not been measured in a controlled setting.

Individual variation is not well characterised. Why some people experience intense effects at amounts others find sub-threshold is not fully explained by current pharmacokinetic data. Age, body weight, and medication use account for some of the variation; the rest is not established.

Long-term effects of regular low-dose exposure are essentially unstudied. The clinical literature is dominated by acute poisoning cases. What regular consumption below the intoxication threshold does, or does not do, over months or years is an open question in the peer-reviewed literature.

Summary

Mad honey does not get you high in any pharmacological sense that the word usually carries. It produces real physiological effects, including slowed heart rate, lowered blood pressure, dizziness, tingling, and altered sensation, through grayanotoxin’s disruption of voltage-gated sodium channels. Those effects can be disorienting and, at high doses, are medically serious.

The ‘high’ framing is a category error: it places mad honey in the same class as psychedelics that work through cortical serotonin receptor pharmacology, which GTX does not touch. The practical consequence of that error is a dose-calibration problem; people using psychedelic reference points to gauge their consumption are using the wrong model for a compound with a narrower safety margin and a primary cardiovascular mechanism.

The effects are real. The mechanism is specific. The classification is not psychedelic.

Want the full mechanism, including why grayanotoxin acts on sodium channels rather than serotonin receptors? “Hallucinogenic Honey” Explained: What the Science Actually Says